Citation: | HUANG Lining, NIU Weiqiao, HUANG Bo, JIANG Xinwei, QIAO Zhiming. Application of selective hepatic inflow occlusion in laparoscopic hepatectomy[J]. Journal of Clinical Medicine in Practice, 2025, 29(7): 76-81. DOI: 10.7619/jcmp.20250198 |
To investigate the safety and efficacy of selective hepatic inflow occlusion in laparoscopic hepatectomy.
A retrospective analysis was conducted on the clinical data of 64 patients who underwent laparoscopic hepatectomy. Based on the different methods of hepatic inflow occlusion, the patients were divided into Pringle occlusion group with 31 patients (using intermittent Pringle's maneuver) and selective occlusion group with 33 patients (using selective hepatic inflow occlusion). The general, intraoperative, and postoperative data were compared between the two groups.
There were no statistically significant differences in general data, operative time, intraoperative blood loss, central venous pressure, and mean arterial pressure between the two groups (P>0.05). On postoperative day 3, the levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBil) in the selective occlusion group were lower than those in the Pringle occlusion group (P < 0.05). There were no statistically significant differences in length of hospital stay and postoperative complication rates between the two groups (P>0.05). Subgroup analysis showed that in patients undergoing laparoscopic hemihepatectomy, the AST and ALT levels on postoperative day 3 were lower in the selective occlusion group than in the Pringle occlusion group (P < 0.05). In patients undergoing laparoscopic liver segmentectomy, the TBil level on postoperative day 3 was lower in the selective occlusion group than in the Pringle occlusion group (P < 0.05), but there were no statistically significant differences in AST and ALT levels between the two groups (P>0.05).
Selective hepatic inflow occlusion demonstrates good safety and efficacy in laparoscopic hepatectomy. It can significantly reduce postoperative liver function damage, especially in patients undergoing hemihepatectomy.
[1] |
赵贞达, 吕君波, 邵文琪. 腹腔镜解剖性右半肝切除术治疗原发性肝癌患者的可行性与安全性[J]. 癌症进展, 2024, 22(8): 863-867, 871.
|
[2] |
LI H, MENG L Z, YU S M, et al. Efficacy and safety of robotic versus laparoscopic liver resection for hepatocellular carcinoma: a propensity score-matched retrospective cohort study[J]. Hepatol Int, 2024, 18(4): 1271-1285. doi: 10.1007/s12072-024-10658-6
|
[3] |
WANG X R, LI J W, CAO J, et al. Approaches of laparoscopic anatomical liver resection of segment 8 for hepatocellular carcinoma: a retrospective cohort study of short-term results at multiple centers in China[J]. Int J Surg, 2023, 109(11): 3365-3374.
|
[4] |
蔡秀军, 张斌, 陈鸣宇, 等. 我国腹腔镜肝切除术近10年进展与发展趋势[J]. 中国实用外科杂志, 2022, 42(9): 961-964.
|
[5] |
中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J]. 中华肝脏病杂志, 2024, 32(7): 581-630.
|
[6] |
夏俊, 贾冉, 钱叶本, 等. 控制性第一肝门阻断法在肝切除手术中的安全性和有效性[J]. 中华肝胆外科杂志, 2021, 27(12): 889-893.
|
[7] |
殷强, 胡勇军, 汪磊, 等. 三维重建技术在肝癌腹腔镜肝切除术中的应用体会[J]. 临床外科杂志, 2024, 32(5): 499-501.
|
[8] |
王冠男, 王小明, 韩猛, 等. 腹腔镜肝切除术100例手术体会[J]. 皖南医学院学报, 2024, 43(1): 45-48.
|
[9] |
郑树国, 王保林. 腹腔镜肝切除术中出血的风险因素及对策[J]. 中国实用外科杂志, 2022, 42(9): 970-974.
|
[10] |
卢冰, 李海, 邓东锋, 等. 原发性肝癌患者行肝癌切除术中不同血流阻断方式的应用效果分析[J]. 中国实用医刊, 2024, 51(4): 1-4.
|
[11] |
黄少坚, 李芷西, 梁汉标, 等. 腹腔镜肝切除术中转开放手术危险因素分析及风险预测模型的建立[J]. 中国实用外科杂志, 2023, 43(5): 566-571.
|
[12] |
金兆星, 邱国腾, 薛帅, 等. 腹腔镜下肝尾状叶切除术的安全性及可行性研究[J]. 腹部外科, 2023, 36(3): 222-226, 231.
|
[13] |
陈亚进, 周睿. 重视腹腔镜肝切除手术的安全性[J]. 中国实用外科杂志, 2022, 42(9): 965-969.
|
[14] |
洪汉崟, 蓝伟锋, 陈永标, 等. Glisson蒂鞘外法和鞘内法在腹腔镜肝细胞癌切除术中的倾向性评分匹配研究[J]. 中华普通外科杂志, 2023, 38(10): 760-764.
|
[15] |
王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志: 电子版, 2024, 18(1): 37-40.
|
[16] |
杜秋国, 李凯, 张日新, 等. 三维可视化、荧光影像联合术中超声在腹腔镜解剖性肝切除术中的应用[J]. 腹部外科, 2024, 37(3): 190-194.
|
[17] |
李晓举, 王星入, 万丹丹, 等. 三维可视化联合术中超声在腹腔镜肝癌切除患者中的近期效果[J]. 肝胆胰外科杂志, 2023, 35(1): 30-35.
|
[18] |
舒强, 刘小玲, 徐波. Glisson蒂横断法与Pringle法在肝细胞癌肝切除术中的应用效果Meta分析[J]. 中国普通外科杂志, 2022, 31(1): 42-54.
|
[19] |
刘旭, 赵建国, 董勤. 选择性半肝血管阻断与Pringle法在肝肿瘤肝切除术中的应用效果比较[J]. 医学综述, 2022, 28(2): 380-385.
|
[20] |
张代场, 蔡丽, 林枫, 等. 选择性肝血流阻断与全肝门血流阻断对腹腔镜左半肝切除术后肝脏缺血再灌注损伤的影响[J]. 中外医疗, 2022, 41(34): 5-9.
|
[21] |
张小强, 邓英, 李锐. 选择性肝血流阻断应用于腹腔镜肝右后叶切除术临床观察[J]. 甘肃科技纵横, 2023, 52(3): 116-118.
|
[22] |
中华预防医学会肝胆胰疾病预防与控制专业委员会, 中国医疗保健国际交流促进会肝脏肿瘤学分会. 精准制导技术应用于肝脏肿瘤诊断与治疗中国专家共识(2024版)[J]. 中华消化外科杂志, 2024, 23(4): 514-526.
|
[23] |
刘荣, 刘渠, 汪洋, 等. 动态流域理论: 肝脏结构功能学的概念与实践[J]. 中国科学: 生命科学, 2025, 55(1): 90-97.
|
[24] |
刘荣, 王子政, 王兆海, 等. 肝脏动态流域学说与恶性肿瘤靶域切除技术[J]. 解放军医学院学报, 2023, 44(1): 1-5.
|
[1] | CHEN Liting, LIU Huiping, SONG Zhongrui, XU Shang, GUO Yuxiu, SHU Guihua. Clinical value of improved scoring system on amplitude integrated electroencephalogram in early prediction of neonates with bilirubin brain injury[J]. Journal of Clinical Medicine in Practice, 2020, 24(5): 21-23. DOI: 10.7619/jcmp.202005006 |
[2] | CAO Qingqing, ZHOU Jin, LI Yueyue, LIANG Lijuan, LI Yang, PAN Liming, CHEN Jun. High concentration of human serum albumin versus low concentration of human serum albumin in patients with primary hepatocellular carcinoma after hemihepatectomy[J]. Journal of Clinical Medicine in Practice, 2018, (21): 46-48. DOI: 10.7619/jcmp.201821014 |
[3] | HAN Jing, XIAO Li, ZHANG Hui, XIAN Jianchun, LI Xiaoqin, GENG Aiwen. Clinical analysis of 40 patients with EB viral hepatitis[J]. Journal of Clinical Medicine in Practice, 2018, (5): 23-25. DOI: 10.7619/jcmp.201805007 |
[7] | WANG Lixin, FAN Wei. Clinical value of hepatic resection in surgical treatment of patients with hepatic hemangioma[J]. Journal of Clinical Medicine in Practice, 2014, (13): 140-142. DOI: 10.7619/jcmp.201413048 |
[8] | WANG Zongyun, HUANG Jun, CHEN Zuyi, LU Changyou. Application of hemihepatic blood flow occlusion via portal plate in resection of liver cancer[J]. Journal of Clinical Medicine in Practice, 2013, (17): 51-53. DOI: 10.7619/jcmp.201317016 |